<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE GlossaryTerm >
<GlossaryTerm id="CDR0000377722"><TermName>recombinant tissue plasminogen activator</TermName><TermPronunciation>(ree-KOM-bih-nunt TIH-shoo plaz-MIN-oh-jen AK-tih-vay-ter)</TermPronunciation><TermDefinition><DefinitionText>A form of tissue plasminogen activator that is made in the laboratory. It helps dissolve blood clots and is used to treat heart attacks, strokes, and clots in the lungs. It is also being studied in the treatment of cancer. It is a type of systemic thrombolytic agent. Also called Activase, Alteplase,  and r-tPA.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><MediaLink ref="CDR0000713455" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;recombinant tissue plasminogen activator&quot;" language="en" id="_3"/><MediaLink ref="CDR0000713454" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;activador del plasminógeno tisular recombinado&quot;" language="es" id="_4"/><SpanishTermName>activador del plasminógeno tisular recombinado</SpanishTermName><SpanishTermDefinition><DefinitionText>Forma de activador del plasminógeno tisular que se produce en el laboratorio. Ayuda a disolver los coágulos de sangre y se usa para tratar ataques cardíacos, accidentes cerebrovasculares y coágulos en los pulmones. Asimismo, está en estudio para el tratamiento de cáncer. Es un tipo de trombolítico sistémico. También se llama Activase, Alteplase,  y r-tPA.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateFirstPublished>2004-06-23</DateFirstPublished><DateLastModified>2007-07-02</DateLastModified></GlossaryTerm>
